Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors
- PMID: 1847844
- PMCID: PMC11038158
- DOI: 10.1007/BF01789045
Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors
Abstract
Tumor-infiltrating lymphocytes (TIL) were isolated from 22 human primary and metastatic liver tumors, and expanded in vitro in the presence of either interleukin-2 (IL-2, 100 U/ml) plus tumor necrosis factor alpha (TNF alpha, 1000 U/ml), IL-2 (1000 U/ml) plus IL-4 (1000 U/ml) or IL-2 (1000 U/ml) alone. TIL proliferated in culture in 20/22 cases. Among different cytoline combination, TNF alpha and IL-2 were most effective in promoting the outgrowth of CD3+CD8+T lymphocytes (mean +/- SEM: 90% +/- 5) in the cultures of TIL from primary liver tumors. Cytotoxicity against autologous tumor cells was demonstrated in all early cultures of TIL from primary liver cancers in the presence of IL-2 plus TNF alpha. In contrast, cultures of TIL derived from colon cancer metastatic to liver had significantly lower levels of autotumor cytotoxicity and proportions of CD3+CD8+ cells (40% +/- 13) than those of TIL from primary liver tumors. The addition on day 0 of interferons (alpha or gamma) to TIL cultured in the presence of TNF alpha and IL-2, significantly augmented cytotoxicity against autologous tumor. In contrast, incubation of TIL in the presence of IL-4 and IL-2 did not result in increased autotumor responses in the cultures of TIL from primary liver tumors. The expansion (-fold) of TIL (day 30) cultured in the presence of IL-2 alone compared to that in the presence of TNF alpha and IL-2 was significantly greater for hepatocellular carcinoma (median, 280 vs 260) than for autologous peripheral blood lymphocytes (36 vs 27), cholangiocarcinoma (42 vs 51) or TIL from metastatic colon cancer (39 vs 30). Outgrowth of TIL in IL-2 plus TNF alpha offers an opportunity for in vitro enrichment in cells with autotumor cytotoxicity in primary liver tumors. However, this cytokine combination was unable to promote and sustain growth of autotumor effectors from TIL in metastatic liver cancer.
Similar articles
-
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.Clin Immunol Immunopathol. 1994 Aug;72(2):237-47. doi: 10.1006/clin.1994.1137. Clin Immunol Immunopathol. 1994. PMID: 8050198
-
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.Cancer Res. 1989 Nov 1;49(21):5979-85. Cancer Res. 1989. PMID: 2507139
-
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.Cancer. 1994 Aug 15;74(4):1275-82. doi: 10.1002/1097-0142(19940815)74:4<1275::aid-cncr2820740416>3.0.co;2-q. Cancer. 1994. PMID: 7914469
-
Resident research award: tumor necrosis factor alpha selectively enhances growth and cytotoxic activity of tumor infiltrating lymphocytes from human colorectal cancer.J Surg Res. 1992 Jan;52(1):39-45. doi: 10.1016/0022-4804(92)90276-6. J Surg Res. 1992. PMID: 1548866
-
The prognostic value of liver tumor T cell infiltrates.J Surg Res. 2014 Sep;191(1):189-95. doi: 10.1016/j.jss.2014.06.001. Epub 2014 Jun 7. J Surg Res. 2014. PMID: 25033707 Free PMC article. Review.
Cited by
-
Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.Br J Cancer. 1994 Oct;70(4):625-30. doi: 10.1038/bjc.1994.361. Br J Cancer. 1994. PMID: 7917907 Free PMC article.
-
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.Cancer Immunol Immunother. 1994 Jul;39(1):15-21. doi: 10.1007/BF01517175. Cancer Immunol Immunother. 1994. PMID: 8044822 Free PMC article. Review. No abstract available.
-
Analysis of T cell receptor variability in fresh tumor-infiltrating lymphocytes from human head and neck cancer.Jpn J Cancer Res. 1994 Jun;85(6):626-32. doi: 10.1111/j.1349-7006.1994.tb02405.x. Jpn J Cancer Res. 1994. PMID: 8063616 Free PMC article.
-
Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.Cancer Immunol Immunother. 1993;36(1):1-8. doi: 10.1007/BF01789124. Cancer Immunol Immunother. 1993. PMID: 8422663 Free PMC article.
-
Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: removal of tumour cells does not affect tumour-specificity.Cancer Immunol Immunother. 1995 Nov;41(5):293-301. doi: 10.1007/BF01517217. Cancer Immunol Immunother. 1995. PMID: 8536275 Free PMC article.
References
-
- Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R. Growth factor production by human colon carcinoma cell lines. Cancer Res. 1989;49:2898–2904. - PubMed
-
- Cameron RB, McIntosh JK, Rosenberg SA. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid α-interferon in the treatment of established murine hepatic metastases. Cancer Res. 1988;48:5810–5817. - PubMed
-
- Chen LK, Tourvieille B, Burns GF, Bach FH, Mathieu-Mahul D, Sasportes M, Bensussan A. Interferon: a cytotoxic T lymphocyte differentiation signal. Eur J Immunol. 1986;16:767–770. - PubMed
-
- Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, Landolfo S, Forni G. Obligatory role of IFNγ in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J Immunol. 1988;141:2831–2836. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials